Pyridostigmine is a carbamate-class acetylcholinesterase inhibitor primarily prescribed to treat myasthenia gravis by enhancing neuromuscular transmission to improve muscle strength. This category features… Read more











Pyridostigmine is a carbamate-class acetylcholinesterase inhibitor primarily prescribed to treat myasthenia gravis by enhancing neuromuscular transmission to improve muscle strength. This category features a comprehensive range of reference standards, including the active pharmaceutical ingredient and its common bromide salt, designed to support rigorous pharmaceutical analysis. Laboratory professionals utilize these materials for impurity profiling, method development, and quality control, ensuring compliance with regulatory standards. The selection includes characterized impurities such as related compounds A and B, which are essential for identifying and quantifying potential degradation products or synthesis by-products. Additionally, stable isotope labelled compounds, including deuterated analogs like pyridostigmine-d3 and pyridostigmine-d6 bromide, provide crucial internal standards for mass spectrometry-based assays, enabling precise quantification and pharmacokinetic studies of the drug in complex matrices during stability testing and method validation procedures.